Insulin patch pumps market seen reaching $2.55 billion by 2030

The insulin patch pumps market is projected to grow from $1.56 billion in 2025 to $2.55 billion by 2030 as diabetes rates rise and demand grows for more convenient insulin delivery. North America held the largest share in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The insulin patch pumps market is tied to the rising global burden of diabetes and the shift toward easier, more personalized insulin delivery. - Growth in patch pumps could support broader use of wearable diabetes technology, remote monitoring, and closed-loop insulin systems.

What happened: - The Business Research Company released its Insulin Patch Pumps Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on August 12, 2026. - The report values the market at $1.56 billion in 2025 and projects $1.73 billion in 2026. - The report forecasts the market will reach $2.55 billion by 2030. - The report also includes a free sample and the full market report.

The details: - The report pegs 2025-2026 growth at a 10.8% compound annual growth rate. - The forecast through 2030 implies a 10.2% CAGR. - Growth has been driven by higher diabetes incidence, demand for intensive insulin therapy, wider adoption of insulin pumps, wearable medical technology advances, and better patient awareness of diabetes management tools. - Future growth is expected to come from closed-loop insulin delivery systems, digital diabetes care platforms, personalized insulin therapy, remote glucose monitoring, and smaller pump devices. - Insulin patch pumps are compact, computerized devices that deliver predetermined insulin doses directly to patients. - Users can wear the devices discreetly under clothing, in a pocket, on a waist belt, or attached with a patch to the stomach or arm. - The devices are positioned as a more convenient alternative to traditional injections. - North America held the largest regional market share in 2025. - Asia-Pacific is projected to grow the fastest over the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market forecast suggests insulin delivery is shifting from manual treatment routines toward connected, lower-friction systems that fit into everyday wearables. - Better diabetes care processes in the UK point to stronger diagnosis and management infrastructure, which can increase demand for advanced insulin delivery tools. - The Office for Health Improvement & Disparities said in March 2024 that, between March 2022 and March 2023, the share of people with type 1 diabetes receiving all eight recommended care processes rose 22%, while the figure for type 2 diabetes rose 21%. - The National Diabetes Audit reported a record 37.9% of patients reaching target HbA1c levels.

What's next: - The report expects continued growth through 2030 as diabetes prevalence rises and more patients adopt connected care tools. - Companies in the category may focus on smaller devices, remote glucose monitoring, and closed-loop systems to capture demand. - The Business Research Company is offering follow-up contact through its sales and research teams for report access and related market analysis.

The bottom line: - Insulin patch pumps are moving from a niche diabetes device category toward a faster-growing wearable health technology market, with the strongest expansion expected in Asia-Pacific.